| Lonafarnib | IC50 | 1.9 [1] |
| CID 395754 | IC50 | 0.5 [1] |
| N-Ethyl-2-(2-phenyl-1H-indol-3-yl)-N-pyridin-4-ylmethyl-acetamide | IC50 | 106.0 [1] |
| 4-[(5-{[4-(3-Chlorophenyl)-3-oxopiperazin-1-YL]methyl}-1H-imidazol-1-YL)methyl]benzonitrile | IC50 | 2.0 [1] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-pyridin-4-ylethanone | IC50 | 250.0 [1] |
| Tipifarnib | IC50 | 0.9 [1] |
| Bms-214662 | IC50 | 1.35 [1] |
| 1-[4-[(2S)-6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperazin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 1500.0 [1] |
| (2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2R)-2-Amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 200.0 [1], 340.0 [2], 420.0 [3] |
| (2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2R)-2-Amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoic acid | Ki | 1100.0 [1] |
| 1-[4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 90.0 [1] |
| Chaetomellic acid A | IC50 | 55.0 [1], 60.0 [2], 175.0 [3], 180.0 [4] |
| 3-Oxo-18-oxa-2,5,9,11-tetrazahexacyclo[17.6.2.22,5.113,17.07,11.022,26]triaconta-1(25),7,9,13(28),14,16,19(27),20,22(26),23-decaene-16-carbonitrile | IC50 | 0.1 [1], 0.2 [2], 0.29 [3] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-pyridin-4-ylethanone | IC50 | 36.0 [1], 160.0 [2], 360.0 [3], 3700.0 [4] |
| (2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-Amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 25.0 [1], 37.0 [2], 600.0 [3], 1000.0 [4] |
| 1-[4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 47.0 [1], 450.0 [2], 1200.0 [3], 4000.0 [4] |
| (2S)-2-[[4-[(1H-Imidazol-5-ylmethylamino)methyl]-2-(2-methylphenyl)benzoyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 0.86 [1], 1.0 [2], 1.4 [3], 1.8 [4] |
| 4-[2-[4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide | IC50 | 49.0 [1], 590.0 [2] |
| (4E,8E)-2-[(E)-3-[5-[[[(2S)-1-[[(2S)-1-[[(1S)-1-Carboxy-3-methylsulfanylpropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]methyl]-1-methylimidazol-2-yl]prop-2-enyl]-2-ethoxycarbonyl-5,9,13-trimethyltetradeca-4,8,12-trienoic acid | IC50 | 640.0 [1] |
| (4E,8E)-2-[(E)-3-[5-[[[(2S)-1-[[(2S)-1-[[(1S)-1-Carboxy-3-methylsulfanylpropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]methyl]-1-methylimidazol-2-yl]prop-2-enyl]-2-ethoxycarbonyl-5,9,13-trimethyltetradeca-4,8,12-trienoic acid | Ki | 500.0 [1], 15000.0 [2], 17000.0 [3] |
| (4E,8E)-2-[3-[5-[[[(2S)-1-[[(2S)-1-[[(1S)-1-Carboxy-3-methylsulfanylpropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]methyl]-1-methylimidazol-2-yl]propyl]-2-ethoxycarbonyl-5,9,13-trimethyltetradeca-4,8,12-trienoic acid | IC50 | 240.0 [1] |
| (4E,8E)-2-[3-[5-[[[(2S)-1-[[(2S)-1-[[(1S)-1-Carboxy-3-methylsulfanylpropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]methyl]-1-methylimidazol-2-yl]propyl]-2-ethoxycarbonyl-5,9,13-trimethyltetradeca-4,8,12-trienoic acid | Ki | 230.0 [1], 5600.0 [2], 7700.0 [3] |
| 2-[4-((R)-2-Amino-3-mercapto-propylamino)-2-naphthalen-1-yl-benzoylamino]-4-methyl-pentanoic acid | IC50 | 54.0 [1], 200.0 [2], 203.0 [3] |
| [4-(3-Pyridyloxymethyl)-2-(2-methylphenyl)benzoyl]methionine | IC50 | 0.4 [1] |
| 1-[4-[(2R)-6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperazin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 25.0 [1], 26.0 [2], 500.0 [3] |
| 4-[[5-[[[(3S)-1-[(3-Chlorophenyl)methyl]-2-oxopyrrolidin-3-yl]amino]methyl]imidazol-1-yl]methyl]benzonitrile | IC50 | 0.52 [1], 1.9 [2] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 530.0 [1] |
| 2'-Methoxy-4'-[[(R)-2-amino-3-mercaptopropyl]amino]biphenyl-3-carboxylic acid | IC50 | 37.0 [1], 40.0 [2] |
| 4-[2-[4-[(2S)-6,15-Dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide | IC50 | 94.0 [1], 378.0 [2], 2000.0 [3] |
| 2-[3-(3-Ethyl-1-methyl-2-oxo-azepan-3-yl)-phenoxy]-4-imidazol-1-ylmethyl-benzonitrile | IC50 | 2.9 [1], 3.0 [2] |
| [2-Oxo-2-[[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]amino]ethyl]phosphonic acid | IC50 | 3500.0 [1], 8700.0 [2], 18500.0 [3] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-pyridin-3-ylethanone | IC50 | 530.0 [1], 1000.0 [2], 6220.0 [3] |
| 4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-N-pyridin-4-ylpiperazine-1-carboxamide | IC50 | 900.0 [1], 940.0 [2], 10500.0 [3] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-phenylethanone | IC50 | 2700.0 [1], 2730.0 [2], 12000.0 [3] |
| 4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-N-pyridin-2-ylpiperazine-1-carboxamide | IC50 | 950.0 [1], 1300.0 [2] |
| 4-[2-[4-[(2R)-6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide | IC50 | 43.0 [1], 350.0 [2] |
| 1-[4-[(2R)-6,15-Dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-(1-oxidopyridin-1-ium-4-yl)ethanone | IC50 | 1.3 [1], 2.0 [2], 10.0 [3] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)piperazin-1-yl]-2-pyridin-2-ylethanone | IC50 | 360.0 [1], 5000.0 [2] |
| 4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-N-pyridin-3-ylpiperazine-1-carboxamide | IC50 | 1300.0 [1], 1340.0 [2], 4800.0 [3] |
| 1-[4-[(2S)-6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperazin-1-yl]-2-(1-methylpiperidin-4-yl)ethanone | IC50 | 50.0 [1], 900.0 [2] |
| 4-[(1S)-1-Amino-1-(3-methylimidazol-4-yl)ethyl]-2-[3-[(3S)-3-ethyl-1-methyl-2-oxoazepan-3-yl]phenoxy]benzonitrile | IC50 | 0.06 [1] |
| 4-[2-[4-[(2S)-6,12-Dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide | IC50 | 5.0 [1], 325.0 [2] |
| 4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-cyclohexyl-2-N-(3-imidazol-1-ylpropyl)piperazine-1,2-dicarboxamide | IC50 | 0.1 [1], 0.56 [2], 1.5 [3] |
| Gliotoxin | IC50 | 1100.0 [1], 80000.0 [2] |
| CID 3005532 | IC50 | 0.5 [1], 40.0 [2] |
| Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylpentanoate | IC50 | 17.0 [1], 30000.0 [2] |
| Halenaquinone | IC50 | 930.0 [1] |
| Clavaric acid | IC50 | 350.0 [1], 1300.0 [2] |
| (1R,8R,9S,13S)-11-[2-(2-Methoxyphenyl)prop-2-enoyl]-1-phenyl-11-azatetracyclo[6.5.2.02,7.09,13]pentadeca-2,4,6-triene-9-carboxylic acid | IC50 | 50.0 [1] |
| (1R,8R,9S,13S)-11-[2-(2-Methoxyphenyl)prop-2-enoyl]-1-phenyl-11-azatetracyclo[6.5.2.02,7.09,13]pentadeca-2,4,6-triene-9-carboxylic acid | Ki | 25.0 [1] |
| (2S)-2-[[4-[[Butyl(2-cyclohexylethyl)amino]methyl]-2-(2-methylphenyl)benzoyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 1.1 [1] |
| 3-(4-Chlorophenyl)-4-cyano-5-(isopropylthio)thiophene-2-carboxylic acid | IC50 | 16000.0 [1] |
| (S)-2-{[5-((R)-2-Amino-3-mercapto-propylamino)-biphenyl-2-carbonyl]-amino}-4-methyl-pentanoic acid | IC50 | 25.0 [1], 183.0 [2] |
| H-Cys-4-Abz-Met-OH | IC50 | 72.0 [1], 150.0 [2] |
| Clavarinone | IC50 | 8000.0 [1], 15000.0 [2] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-phenylethanone | IC50 | 800.0 [1] |
| [(2Z,6E)-7,11-Dimethyl-3-prop-2-enyldodeca-2,6,10-trienyl] phosphono hydrogen phosphate | IC50 | 119.0 [1], 189.0 [2] |
| (2S)-2-[[(3S)-2-[(2S)-2-[2-(1H-Imidazol-5-yl)ethylamino]-3-methylbutanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 0.79 [1], 0.8 [2] |
| [(2Z,6E)-3-Ethenyl-7,11-dimethyldodeca-2,6,10-trienyl] phosphono hydrogen phosphate | IC50 | 173.0 [1] |
| 6-[alpha-(1-Methyl-5-imidazolyl)-4-cyanobenzyloxymethyl]biphenyl-3-carbonitrile | IC50 | 1.3 [1], 1318.26 [2] |
| (1R,5R)-30-Oxo-19-oxa-2,6,10,12-tetrazahexacyclo[18.6.2.12,5.114,18.08,12.023,27]triaconta-8,10,14(29),15,17,20(28),21,23(27)-octaene-17-carbonitrile | IC50 | 0.02 [1], 1.0 [2] |
| 4'-[[(R)-2-Amino-3-mercaptopropyl]amino]biphenyl-3-carboxylic acid | IC50 | 114.0 [1], 150.0 [2] |
| [1-[[3-(1,3-Benzodioxol-5-ylmethyl)imidazol-4-yl]methyl]-4-naphthalen-1-ylpyrrol-3-yl]-(4-methylpiperazin-1-yl)methanone | IC50 | 0.9 [1], 2.4 [2] |
| (2S)-2-[[2-[[(2S,3R)-2-[[2-[3-[(4-Cyanophenyl)methyl]imidazol-4-yl]acetyl]amino]-3-methylpentyl]-(naphthalen-1-ylmethyl)amino]acetyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 0.15 [1] |
| 4-[3-(4-Cyanophenyl)-3-hydroxy-3-(3-methylimidazol-4-yl)prop-1-ynyl]-3-(3-ethoxyphenyl)benzonitrile | IC50 | 0.73 [1] |
| 4-{5-[(1-Benzyl-2-oxo-pyrrolidin-3-ylamino)-methyl]-imidazol-1-ylmethyl}-benzonitrile | IC50 | 5.7 [1], 29.0 [2] |
| 6-[[(4-Cyano-3-naphthalen-1-ylphenyl)-(3-methylimidazol-4-yl)methoxy]methyl]pyridine-3-carbonitrile | IC50 | 0.4 [1], 0.73 [2] |
| (1R,5R)-29-Oxo-19-oxa-2,6,10,12-tetrazahexacyclo[18.5.2.12,5.114,18.08,12.023,26]nonacosa-8,10,14(28),15,17,20(27),21,23(26)-octaene-17-carbonitrile | IC50 | 0.15 [1], 1.0 [2] |
| 1-[4-[(2S)-13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperazin-1-yl]-2-pyridin-4-ylethanone | IC50 | 140.0 [1] |
| (5S)-30-Oxo-19-oxa-2,6,10,12-tetrazahexacyclo[18.6.2.12,5.114,18.08,12.023,27]triaconta-1(26),8,10,14(29),15,17,20(28),21,23(27),24-decaene-17-carbonitrile | IC50 | 3.5 [1] |
| [(2Z,6E)-3-Tert-butyl-7,11-dimethyldodeca-2,6,10-trienyl] phosphono hydrogen phosphate | IC50 | 31.0 [1] |
| [1-(1H-Imidazol-5-ylmethyl)-7-pyridin-4-yl-3,5-dihydro-2H-1,4-benzodiazepin-4-yl]-[2-(trifluoromethoxy)phenyl]methanone | IC50 | 24.0 [1], 24000.0 [2] |
| 1-[(2R)-2-[(4-Cyanophenyl)methyl-methylamino]-3-(3-methylimidazol-4-yl)propanoyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-4-carbonitrile | IC50 | 0.92 [1] |
| Methyl (2S)-2-[[6-[[(2R)-2-amino-3-sulfanylpropyl]amino]naphthalene-1-carbonyl]amino]-4-methylsulfanylbutanoate | IC50 | 80.0 [1], 500.0 [2] |
| 2-[4-(2-Amino-3-mercapto-propylamino)-benzoylamino]-4-methylsulfanyl-butyric acid | IC50 | 150.0 [1] |
| 2-[4-(2-Amino-3-mercapto-propylamino)-benzoylamino]-4-methylsulfanyl-butyric acid | Ki | 785.0 [1] |
| 1-[4-[(4-Chlorophenyl)-pyridin-2-ylmethyl]piperazin-1-yl]-2-pyridin-3-ylethanone | IC50 | 38300.0 [1] |
| (R)-2-Amino-3-(biphenyl-4-ylamino)-propane-1-thiol | IC50 | 1070.0 [1], 1200.0 [2] |
| (R)-2-Amino-3-[(3'-methyl-1,1'-biphenyl-4-yl)amino]-1-propanethiol | IC50 | 710.0 [1], 770.0 [2] |
| 4'-[[(R)-2-Amino-3-mercaptopropyl]amino]biphenyl-3-carboxylic acid methyl ester | IC50 | 917.0 [1], 930.0 [2] |
| 7-Bromo-4-(1-naphthylcarbonyl)-1-(1H-imidazole-5-ylmethyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine | IC50 | 228.0 [1], 228000.0 [2] |
| (S)-4-((5-((1-(3-Chlorobenzoyl)pyrrolidin-3-ylamino)methyl)-1H-imidazol-1-yl)methyl)benzonitrile | IC50 | 27.0 [1], 67.0 [2] |
| Tert-butyl N-[3-[[(3S)-1-benzyl-2-oxopyrrolidin-3-yl]-[[3-[(4-cyanophenyl)methyl]imidazol-4-yl]methyl]amino]propyl]carbamate | IC50 | 18.0 [1], 65.0 [2] |
| 4-[[5-[[[(3S)-1-Benzyl-2-oxopyrrolidin-3-yl]-(pyridin-3-ylmethyl)amino]methyl]imidazol-1-yl]methyl]benzonitrile | IC50 | 52.0 [1], 110.0 [2] |
| 4-(5-{[(1-Benzyl-2-oxo-pyrrolidin-3-yl)-butyl-amino]-methyl}-imidazol-1-ylmethyl)-benzonitrile | IC50 | 42.0 [1], 54.0 [2] |
| 4-{5-[2-(2-Oxo-1-phenyl-pyrrolidin-3-ylamino)-ethyl]-imidazol-1-ylmethyl}-benzonitrile | IC50 | 150.0 [1], 280.0 [2] |
| (2S)-4-Methylsulfanyl-2-[[2-phenyl-4-[[3-[(4-phenylphenyl)methyl]imidazol-4-yl]methylamino]benzoyl]amino]butanoic acid | IC50 | 8.0 [1], 260.0 [2] |
| 1-[4-(13-Chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-pyridin-3-ylethanone | IC50 | 470.0 [1], 600.0 [2] |
| [4-((R)-2-Amino-3-mercapto-propyl)-3-butyl-piperazin-1-yl]-naphthalen-1-yl-methanone | IC50 | 1.0 [1] |
| 1-[4-(13-Chloro-6-methyl-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-2-pyridin-4-ylethanone | IC50 | 40.0 [1], 60.0 [2] |
| 2-(2-Naphthyloxy)-4-[5-[3-oxo-4-(3-chlorophenyl)piperazinomethyl]-1-imidazolylmethyl]benzonitrile | IC50 | 48.0 [1], 1000.0 [2] |
| (Z)-2-((Z)-Hexadec-7-enyl)-3-methyl-but-2-enedioic acid | IC50 | 185.0 [1], 190.0 [2] |
| 4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-cyclohexyl-2-N-(1,3,4-thiadiazol-2-yl)piperazine-1,2-dicarboxamide | IC50 | 490.0 [1], 10000.0 [2] |
| 4-(6-Bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-cyclohexyl-2-N-[(6-methylpyridin-3-yl)methyl]piperazine-1,2-dicarboxamide | IC50 | 61.0 [1], 550.0 [2] |
| 4-[3-(4-Cyanophenyl)-3-hydroxy-3-(3-methylimidazol-4-yl)prop-1-ynyl]-3-(3-methoxyphenyl)benzonitrile | IC50 | 0.37 [1] |
| Orhalquinone | IC50 | 410.0 [1] |
| (2S)-2-[[2-[[(2S,3R)-2-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-3-methylpentyl]-benzylamino]acetyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 1.2 [1] |
| 4-[[5-[[[(3S)-1-Benzyl-2-oxopyrrolidin-3-yl]-(3-phenylpropyl)amino]methyl]imidazol-1-yl]methyl]benzonitrile | IC50 | 15.0 [1], 74.0 [2] |
| 4-[[5-[[3-Aminopropyl-[(3S)-1-benzyl-2-oxopyrrolidin-3-yl]amino]methyl]imidazol-1-yl]methyl]benzonitrile | IC50 | 17.0 [1], 1100.0 [2] |
| 4-[5-[[(3S)-1-(4-Pyridyl)-2-oxo-3-pyrrolidinyl]aminomethyl]-1H-imidazole-1-ylmethyl]benzonitrile | IC50 | 43.0 [1], 200.0 [2] |